Integra LifeSciences Holdings Corp Stock
The Integra LifeSciences Holdings Corp price is unchanged compared to yesterday.
Currently there is a rather negative sentiment for Integra LifeSciences Holdings Corp with 1 Buy predictions and 4 Sell predictions..
With a target price of 9 € there is a slightly negative potential of -3.74% for Integra LifeSciences Holdings Corp compared to the current price of 9.35 €.
Pros and Cons of Integra LifeSciences Holdings Corp in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Integra LifeSciences Holdings Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corp | 0.000% | -5.155% | -9.804% | -63.200% | -13.208% | -83.273% | -83.571% |
| Bio-Rad Labs Inc. A | -0.890% | 0.079% | -3.223% | -26.322% | -2.210% | -42.734% | -49.153% |
| Neogen Corp. | 4.600% | 2.959% | 41.463% | -21.622% | 41.463% | - | - |
| Icu Medical Inc. | -0.780% | -3.125% | 5.085% | -21.019% | 0.000% | -30.726% | -26.190% |
Comments
Integra LifeSciences (NASDAQ:IART) had its price target lowered by analysts at Citigroup Inc. from $12.00 to $11.00. They now have a "sell" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences (NASDAQ:IART) had its price target raised by analysts at JPMorgan Chase & Co. from $12.00 to $13.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences (NASDAQ:IART) had its "sell" rating reaffirmed by analysts at Citigroup Inc..
Show more
Ratings data for IART provided by MarketBeat